Organigram: Canaccord Lowers Price Target To $2.50

Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced net revenues of $20.4 million, up 25% year over year, with a $38.6 million net loss. In the year ago period, Organigram had revenues of $86.8 million for the year with a net loss of $136.1 million. Organigram currently has […]

Mind Cure Appoints Kelsey Ramsden As CEO And President

Mind Cure Health (CSE: MCUR) has shaken up its management team slightly, promoting COO Kelsey Ramsden to the role of President and Chief Executive Officer of the company, effective immediately. Former President and CEO Philip Tapley will remain with the company however, where he will continue to serve as Chairman of the board. Ramsden, previously […]

MustGrow Biologics Demonstrates 100% Control Of Panama Disease In Lab Tests

MustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted in Colombia against the Panama Disease. The disease, which has been devastating the global banana industry, has proven to be no match against the firms mustard-derived biopesticide formulation. Testing against the disease with MustGrow’s proprietary formula was conducted by third […]

Hive Blockchain Sees Digital Currency Mining Income Grow 97.4% Quarter Over Quarter

Hive Blockchain Tech (TSXV: HIVE) last night filed its second quarter financial results, reporting revenues of $13.0 million from its digital currency mining, a 97.4% increase over the first quarter revenues of $6.6 million posted by the company. Furthermore, Hive managed to post a net income of $9.3 million, a strong improvement over the $1.3 […]

Kontrol Energy Enters Exclusive Distribution Arrangement Across First Responder And Public Transport Industries

Kontrol Energy Corp (CSE: KNR) this morning announced that it has entered into an exclusive distribution agreement across several specific industries this morning. The arrangement, entered into with that of the United Safety and Survivability Corporation, will see the company provide exclusive distribution terms across a number of industries within North America, Australia, and New […]

PharmaTher To Develop Digital Therapeutics Platform Focused On Psychedelic Therapies

Pharmather Inc (CSE: PHRM) this morning announced that it has amended its sponsored research agreement with that of the University Health Network. The revised agreement, which was originally just focused on the development of panaceAI, will now also include the development of a digital therapeutics platform to combine with potential psychedelic therapies. The digital therapeutics […]